Schering-Plough

Results: 410



#Item
51Press Release  MSD announces its intention to make operational changes in its Belgian entities located in Brussels and its Luxembourg entity Brussels, 9 May 2014 Today, during an extraordinary works council, the directio

Press Release MSD announces its intention to make operational changes in its Belgian entities located in Brussels and its Luxembourg entity Brussels, 9 May 2014 Today, during an extraordinary works council, the directio

Add to Reading List

Source URL: www.msd-belgium.be

Language: English - Date: 2015-05-28 13:02:12
52Microsoft Word - Mexico - January 2008 clean.doc

Microsoft Word - Mexico - January 2008 clean.doc

Add to Reading List

Source URL: wp.aaccla.org

Language: English - Date: 2015-04-21 17:07:31
53Ambulatory Non-resident price schedule 30Sep10.xls

Ambulatory Non-resident price schedule 30Sep10.xls

Add to Reading List

Source URL: www.adhb.govt.nz

Language: English - Date: 2014-09-04 21:34:28
54Vet MERCK_A4_template_pref

Vet MERCK_A4_template_pref

Add to Reading List

Source URL: www.2ndchance.info

Language: English - Date: 2014-02-04 17:40:01
55Zubrin Rapidly-Disintegrating Tablets, NADA, Client Information Sheet, April 2004

Zubrin Rapidly-Disintegrating Tablets, NADA, Client Information Sheet, April 2004

Add to Reading List

Source URL: www.2ndchance.info

Language: English - Date: 2014-02-04 14:29:02
56PUBLIC SUMMARY DOCUMENT Product: Ezetimibe and Atorvastatin, pack containing 30 tablets ezetimibe 10 mg, and 30 tablets atorvastatin 10 mg (as calcium), atorvastatin 20 mg (as calcium), atorvastatin 40 mg (as calcium) or

PUBLIC SUMMARY DOCUMENT Product: Ezetimibe and Atorvastatin, pack containing 30 tablets ezetimibe 10 mg, and 30 tablets atorvastatin 10 mg (as calcium), atorvastatin 20 mg (as calcium), atorvastatin 40 mg (as calcium) or

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:22
57Schering-Plough / Statins / Ezetimibe / Lactams / Organofluorides / Rosuvastatin / Simvastatin / Hypolipidemic agent / Merck & Co. / Chemistry / Organic chemistry / Merck

5.6 EZETIMIBE + ROSUVASTATIN, tablets, ezetimibe 10mg + rosuvastatin 5mg; ezetimibe 10mg + rosuvastatin 10mg; ezetimibe 10mg + rosuvastatin 20mg; ezetimibe 10mg + rosuvastatin 40mg, RosuzetĀ®, Merck Sharp & Dohme Austr

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-04-22 23:39:46
58SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Loradis ** 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg loratadine. Excipient with known effect:

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Loradis ** 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg loratadine. Excipient with known effect:

Add to Reading List

Source URL: mri.medagencies.org

Language: English - Date: 2015-05-08 18:58:02
59SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Lorapharm ** 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg loratadine. Excipient with known effect:

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Lorapharm ** 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg loratadine. Excipient with known effect:

Add to Reading List

Source URL: mri.medagencies.org

Language: English - Date: 2015-05-08 18:57:59
60

PDF Document

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:23